Harnessing the Power of Causal Loop Diagrams for Health Systems Research in Low and Middle-Income Settings

By Staff Writer

September 18, 2023

Health systems are complex due to the numerous elements involved and their interconnected relationships. They evolve over time and in response to external environments. This complexity often leads to unintended consequences when health policies overlook the feedback and relationships between system elements.

To effectively manage and analyse this complexity, researchers need to adopt a ‘systems thinking’ approach. This approach emphasises the connections and relationships between system elements as part of a larger, evolving system. One method to achieve this is through Causal Loop Diagrams (CLDs).

The Power of Causal Loop Diagrams

CLDs provide a visual representation of the relationships between system elements and their interactions. This allows researchers to understand what drives problematic system behaviour. They are particularly useful in resource-constrained health systems, where investments need to be well-targeted. Surprisingly, the use of CLDs has been limited in health systems research in low- and middle-income countries.

CLDs help us understand what actions or mechanisms drive behaviour in a system. They illuminate desirable or undesirable behaviour and can identify spill-over effects of actions or interventions to wider parts of the system.

When designing a CLD study, researchers need to consider the time frame of interest, the boundary of the issue, and the level of system aggregation. The goal should always be to use CLDs to map key structural drivers for a given behaviour or problem of interest, not to map the feedback that drives behaviour in the entire, wider health system.

CLDs can be generated using a variety of data sources, including primary and secondary data. The method chosen for CLD development depends on the purpose of the research and data requirements. The developed CLD then needs to be validated to minimise any unconscious bias that may have been introduced by the researcher during development or misinterpretation of data.

The Potential of CLDs in Health Systems Research

CLDs have the potential to significantly improve health systems research in low- and middle-income settings. By providing a visual representation of the relationships between system elements, they allow researchers to better understand and manage the complexity of health systems. The challenge now is to increase the use of CLDs in these settings.

Reference url

Recent Posts

oral cancer East Africa
   

Oral Cancer in East Africa: The Need for Early Detection

💡 Did you know that Toombak use is a leading risk factor for oral cancer in East Africa?

A recent scoping review sheds light on the shocking prevalence of oral cancer in the region, emphasising the urgent need for public health interventions and improved early detection strategies. Enhancing awareness around risk factors like Toombak, tobacco, and alcohol for tackling this growing health crisis.

Curious about the key insights and their implications for health economics? Look into the full article to find out more!

#SyenzaNews #HealthEconomics #Oncology #GlobalHealth

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.